Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spouses | 26 | 2024 | 70 | 7.460 |
Why?
|
| Caregivers | 18 | 2026 | 573 | 5.730 |
Why?
|
| Interpersonal Relations | 19 | 2019 | 223 | 4.490 |
Why?
|
| Adaptation, Psychological | 25 | 2023 | 431 | 3.930 |
Why?
|
| Head and Neck Neoplasms | 12 | 2025 | 636 | 3.630 |
Why?
|
| Stress, Psychological | 13 | 2025 | 557 | 3.340 |
Why?
|
| Cancer Survivors | 8 | 2025 | 269 | 2.500 |
Why?
|
| Quality of Life | 19 | 2024 | 2089 | 2.470 |
Why?
|
| Breast Neoplasms | 14 | 2025 | 2648 | 2.330 |
Why?
|
| Social Support | 16 | 2025 | 371 | 2.320 |
Why?
|
| Lung Neoplasms | 14 | 2025 | 1538 | 2.240 |
Why?
|
| Neoplasms | 17 | 2025 | 2959 | 2.070 |
Why?
|
| Health Services Needs and Demand | 4 | 2025 | 172 | 1.960 |
Why?
|
| Communicable Disease Control | 6 | 2023 | 140 | 1.880 |
Why?
|
| Surveys and Questionnaires | 24 | 2025 | 4040 | 1.660 |
Why?
|
| Survivors | 11 | 2022 | 348 | 1.570 |
Why?
|
| Communication | 9 | 2017 | 529 | 1.440 |
Why?
|
| Middle Aged | 51 | 2026 | 28510 | 1.330 |
Why?
|
| Life Style | 6 | 2021 | 447 | 1.310 |
Why?
|
| Pain | 7 | 2022 | 432 | 1.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2025 | 906 | 1.260 |
Why?
|
| Aged | 42 | 2025 | 20968 | 1.220 |
Why?
|
| Health Behavior | 4 | 2020 | 389 | 1.160 |
Why?
|
| Psychometrics | 4 | 2025 | 671 | 1.160 |
Why?
|
| Patient Preference | 2 | 2025 | 148 | 1.120 |
Why?
|
| Adult | 41 | 2026 | 31274 | 1.100 |
Why?
|
| Sexual Partners | 6 | 2019 | 81 | 1.080 |
Why?
|
| Female | 65 | 2026 | 70670 | 1.080 |
Why?
|
| Affect | 4 | 2015 | 168 | 1.060 |
Why?
|
| Marriage | 6 | 2016 | 27 | 1.030 |
Why?
|
| Male | 58 | 2026 | 64715 | 1.030 |
Why?
|
| Mouth Neoplasms | 2 | 2017 | 94 | 0.920 |
Why?
|
| Humans | 82 | 2026 | 130842 | 0.920 |
Why?
|
| Self Care | 3 | 2016 | 227 | 0.910 |
Why?
|
| Depression | 6 | 2016 | 1327 | 0.910 |
Why?
|
| Needs Assessment | 4 | 2025 | 176 | 0.900 |
Why?
|
| Employment | 1 | 2025 | 72 | 0.880 |
Why?
|
| Sick Role | 3 | 2010 | 28 | 0.870 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 172 | 0.800 |
Why?
|
| Health Services Accessibility | 2 | 2026 | 696 | 0.760 |
Why?
|
| Mental Health Services | 1 | 2026 | 275 | 0.760 |
Why?
|
| Family Conflict | 3 | 2018 | 17 | 0.740 |
Why?
|
| Family Characteristics | 6 | 2016 | 98 | 0.730 |
Why?
|
| Vulnerable Populations | 1 | 2023 | 151 | 0.700 |
Why?
|
| Mental Health | 2 | 2026 | 382 | 0.700 |
Why?
|
| Qualitative Research | 5 | 2025 | 697 | 0.680 |
Why?
|
| Social Isolation | 1 | 2020 | 43 | 0.660 |
Why?
|
| Radiotherapy | 2 | 2018 | 119 | 0.650 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 138 | 0.640 |
Why?
|
| Self-Management | 2 | 2018 | 115 | 0.620 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 110 | 0.600 |
Why?
|
| Preoperative Period | 1 | 2019 | 91 | 0.580 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 35 | 0.570 |
Why?
|
| Diffusion of Innovation | 1 | 2019 | 84 | 0.560 |
Why?
|
| Guideline Adherence | 1 | 2021 | 391 | 0.560 |
Why?
|
| Medical Records | 3 | 2017 | 181 | 0.550 |
Why?
|
| Self Efficacy | 3 | 2024 | 203 | 0.550 |
Why?
|
| Neoplasm Metastasis | 5 | 2025 | 701 | 0.550 |
Why?
|
| Genetic Testing | 1 | 2025 | 1087 | 0.540 |
Why?
|
| Health Resources | 1 | 2019 | 127 | 0.540 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2025 | 756 | 0.520 |
Why?
|
| Health Status | 3 | 2016 | 385 | 0.520 |
Why?
|
| Social Adjustment | 2 | 2008 | 78 | 0.510 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 459 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3417 | 0.510 |
Why?
|
| Verbal Behavior | 2 | 2008 | 46 | 0.500 |
Why?
|
| Analgesics | 1 | 2017 | 121 | 0.500 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 950 | 0.480 |
Why?
|
| Internet | 2 | 2017 | 418 | 0.480 |
Why?
|
| Patients | 2 | 2015 | 122 | 0.470 |
Why?
|
| Sex Factors | 5 | 2023 | 1342 | 0.470 |
Why?
|
| Prostatic Neoplasms | 4 | 2012 | 1387 | 0.460 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.450 |
Why?
|
| Catastrophization | 1 | 2014 | 18 | 0.440 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2019 | 265 | 0.440 |
Why?
|
| Health Communication | 1 | 2015 | 31 | 0.430 |
Why?
|
| Survivorship | 2 | 2025 | 45 | 0.430 |
Why?
|
| Family Therapy | 1 | 2014 | 33 | 0.420 |
Why?
|
| Longitudinal Studies | 6 | 2025 | 1503 | 0.420 |
Why?
|
| Psychotherapy, Brief | 1 | 2014 | 53 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 650 | 0.410 |
Why?
|
| Social Control, Informal | 1 | 2013 | 4 | 0.400 |
Why?
|
| Human papillomavirus 16 | 1 | 2013 | 97 | 0.380 |
Why?
|
| Biomedical Research | 1 | 2019 | 561 | 0.380 |
Why?
|
| United States | 11 | 2025 | 11839 | 0.380 |
Why?
|
| Disclosure | 3 | 2019 | 150 | 0.370 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 3825 | 0.360 |
Why?
|
| Self Disclosure | 2 | 2011 | 28 | 0.350 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 6784 | 0.350 |
Why?
|
| Pandemics | 3 | 2023 | 1158 | 0.340 |
Why?
|
| Parent-Child Relations | 2 | 2011 | 255 | 0.330 |
Why?
|
| Pain Measurement | 4 | 2017 | 351 | 0.330 |
Why?
|
| Sexual Behavior | 1 | 2012 | 241 | 0.320 |
Why?
|
| Young Adult | 8 | 2021 | 10025 | 0.310 |
Why?
|
| Chronic Pain | 1 | 2011 | 160 | 0.290 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 1307 | 0.290 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 384 | 0.290 |
Why?
|
| Body Weight | 2 | 2017 | 989 | 0.290 |
Why?
|
| Linear Models | 3 | 2021 | 692 | 0.290 |
Why?
|
| Anxiety | 2 | 2023 | 1009 | 0.290 |
Why?
|
| Weight Loss | 3 | 2024 | 526 | 0.280 |
Why?
|
| Speech | 1 | 2008 | 65 | 0.260 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 219 | 0.260 |
Why?
|
| Pilot Projects | 4 | 2018 | 1462 | 0.260 |
Why?
|
| Object Attachment | 1 | 2008 | 62 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2024 | 492 | 0.250 |
Why?
|
| Socioeconomic Factors | 3 | 2024 | 893 | 0.250 |
Why?
|
| Perception | 1 | 2008 | 228 | 0.250 |
Why?
|
| Exercise | 5 | 2024 | 868 | 0.250 |
Why?
|
| Erectile Dysfunction | 1 | 2009 | 197 | 0.250 |
Why?
|
| Internal-External Control | 1 | 2006 | 74 | 0.240 |
Why?
|
| Diet | 2 | 2017 | 1116 | 0.240 |
Why?
|
| Somatoform Disorders | 1 | 2006 | 46 | 0.240 |
Why?
|
| Program Evaluation | 2 | 2023 | 442 | 0.230 |
Why?
|
| Complementary Therapies | 1 | 2025 | 44 | 0.230 |
Why?
|
| Emotions | 2 | 2019 | 355 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 444 | 0.220 |
Why?
|
| Community Health Workers | 1 | 2026 | 79 | 0.220 |
Why?
|
| Continuity of Patient Care | 2 | 2019 | 143 | 0.220 |
Why?
|
| Safety-net Providers | 1 | 2025 | 87 | 0.210 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 507 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 497 | 0.210 |
Why?
|
| Community-Institutional Relations | 1 | 2023 | 31 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2018 | 828 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2016 | 6494 | 0.200 |
Why?
|
| Cost of Illness | 3 | 2013 | 291 | 0.200 |
Why?
|
| Focus Groups | 1 | 2024 | 230 | 0.200 |
Why?
|
| Medically Underserved Area | 1 | 2023 | 88 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2021 | 1247 | 0.190 |
Why?
|
| Family Relations | 3 | 2012 | 75 | 0.180 |
Why?
|
| Neuralgia | 1 | 2022 | 50 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2006 | 453 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 228 | 0.180 |
Why?
|
| Minority Groups | 1 | 2023 | 257 | 0.170 |
Why?
|
| Marital Status | 1 | 2021 | 33 | 0.170 |
Why?
|
| Pain Management | 2 | 2015 | 197 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2005 | 1232 | 0.170 |
Why?
|
| Weight Reduction Programs | 1 | 2021 | 58 | 0.170 |
Why?
|
| Palliative Care | 1 | 2025 | 444 | 0.170 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2012 | 41 | 0.160 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 1307 | 0.160 |
Why?
|
| Educational Status | 1 | 2021 | 276 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 418 | 0.160 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 133 | 0.160 |
Why?
|
| Fever | 1 | 2022 | 307 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 1395 | 0.150 |
Why?
|
| Texas | 2 | 2023 | 3636 | 0.150 |
Why?
|
| Marital Therapy | 2 | 2009 | 2 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2019 | 88 | 0.150 |
Why?
|
| Self Report | 1 | 2022 | 556 | 0.140 |
Why?
|
| Research Design | 2 | 2020 | 718 | 0.140 |
Why?
|
| Telephone | 1 | 2018 | 114 | 0.140 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 119 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2019 | 329 | 0.140 |
Why?
|
| Prescriptions | 1 | 2017 | 44 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 635 | 0.130 |
Why?
|
| Overweight | 1 | 2020 | 379 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 55 | 0.130 |
Why?
|
| Mass Screening | 1 | 2023 | 808 | 0.130 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 95 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2935 | 0.130 |
Why?
|
| Personal Satisfaction | 2 | 2008 | 103 | 0.130 |
Why?
|
| Medical Oncology | 1 | 2018 | 238 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1236 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 226 | 0.120 |
Why?
|
| Dental Care | 1 | 2015 | 8 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2019 | 426 | 0.110 |
Why?
|
| Veterans | 2 | 2024 | 1792 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2849 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2015 | 158 | 0.110 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 99 | 0.110 |
Why?
|
| Language | 1 | 2016 | 216 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2017 | 406 | 0.110 |
Why?
|
| Cognition | 1 | 2019 | 817 | 0.100 |
Why?
|
| Southwestern United States | 1 | 2013 | 46 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2024 | 440 | 0.100 |
Why?
|
| Telemedicine | 1 | 2020 | 518 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 847 | 0.100 |
Why?
|
| Length of Stay | 1 | 2019 | 1398 | 0.100 |
Why?
|
| Social Media | 1 | 2015 | 119 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2020 | 5091 | 0.090 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 9 | 0.090 |
Why?
|
| Age of Onset | 1 | 2013 | 597 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1794 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2012 | 83 | 0.090 |
Why?
|
| Family | 1 | 2014 | 586 | 0.090 |
Why?
|
| Health Promotion | 1 | 2015 | 409 | 0.090 |
Why?
|
| Health Services Research | 1 | 2012 | 179 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2021 | 12912 | 0.080 |
Why?
|
| Karnofsky Performance Status | 1 | 2010 | 13 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1212 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2017 | 812 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2012 | 140 | 0.080 |
Why?
|
| Fruit | 1 | 2011 | 235 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 276 | 0.080 |
Why?
|
| Problem Solving | 1 | 2010 | 60 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2020 | 17681 | 0.080 |
Why?
|
| Orgasm | 1 | 2009 | 6 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 271 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2014 | 1685 | 0.070 |
Why?
|
| Libido | 1 | 2009 | 34 | 0.070 |
Why?
|
| Adolescent | 2 | 2021 | 20835 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2010 | 177 | 0.070 |
Why?
|
| Health Surveys | 1 | 2010 | 261 | 0.070 |
Why?
|
| Psychology | 1 | 2008 | 56 | 0.070 |
Why?
|
| Family Health | 1 | 2009 | 243 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2012 | 557 | 0.070 |
Why?
|
| Self-Help Groups | 1 | 2007 | 14 | 0.070 |
Why?
|
| Psychotherapy, Group | 1 | 2007 | 58 | 0.060 |
Why?
|
| Nausea | 1 | 2006 | 83 | 0.060 |
Why?
|
| Arousal | 1 | 2006 | 77 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2021 | 241 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 138 | 0.060 |
Why?
|
| Fatigue | 1 | 2006 | 195 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2025 | 77 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2007 | 363 | 0.050 |
Why?
|
| Reference Values | 1 | 2005 | 680 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 380 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 946 | 0.050 |
Why?
|
| Disease Progression | 1 | 2010 | 2203 | 0.050 |
Why?
|
| Patient Care Planning | 1 | 2024 | 123 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 5230 | 0.050 |
Why?
|
| Mothers | 2 | 2017 | 369 | 0.050 |
Why?
|
| Obesity | 1 | 2014 | 2390 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2020 | 15013 | 0.050 |
Why?
|
| Emigrants and Immigrants | 1 | 2024 | 169 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2021 | 90 | 0.040 |
Why?
|
| Gait | 1 | 2021 | 133 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 194 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 114 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 988 | 0.040 |
Why?
|
| Deglutition | 1 | 2019 | 56 | 0.040 |
Why?
|
| Algorithms | 1 | 2025 | 1679 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2020 | 293 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2025 | 1841 | 0.030 |
Why?
|
| Time Factors | 1 | 2008 | 6243 | 0.030 |
Why?
|
| Child | 2 | 2020 | 26219 | 0.030 |
Why?
|
| Adult Children | 1 | 2017 | 5 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2850 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2685 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1512 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 501 | 0.030 |
Why?
|
| Nuclear Family | 1 | 2014 | 50 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2013 | 63 | 0.020 |
Why?
|
| Hypnosis | 1 | 2012 | 11 | 0.020 |
Why?
|
| Relaxation Therapy | 1 | 2012 | 24 | 0.020 |
Why?
|
| Biofeedback, Psychology | 1 | 2012 | 38 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 133 | 0.020 |
Why?
|
| Health Education | 1 | 2012 | 227 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2012 | 411 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 717 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 11004 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 138 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1131 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 42 | 0.020 |
Why?
|
| Counseling | 1 | 2008 | 237 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2007 | 109 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2008 | 833 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 3062 | 0.010 |
Why?
|